FAQs
Question 1: I’ve heard about DCVax®-L, what types of cancer can this vaccine be used to treat?
Answer 1: Currently, only patients with primary brain cancer (i.e., cancer that started in the brain) can be treated with DCVax®-L.
Question 2: I’ve heard about DCVax®-L, what types of cancer can this vaccine be used to treat?
Answer 2: The clinical trial is currently enrolling patients who:
• Have newly diagnosed Glioblastoma multiforme (GBM)
• Have not yet had their surgery to remove the tumor
• Are age 18 to 65
• Meet certain additional medical eligibility requirements
• Please contact the nearest clinical trial site listed above for further information regarding eligibility.
Question 3: I have had my tumor previously removed. Am I a candidate for treatment?
Answer 3: Unfortunately, no. At least some amount of tumor tissue is needed in order to manufacture the vaccine. Without such tumor tissue, DCVax®-L would not be able to be manufactured unless and until a tumor recurrence happens. Fresh tumor is required; pathology and other stored samples cannot be used at this point.
Question 4: Where are the clinical trials being conducted in the United States that are testing the DCVax®-L therapy?
Answer 4: Currently there are twelve sites in the United States that are enrolling patients for DCVax®-L vaccine treating newly diagnosed Glioblastoma multiforme (GBM).
For a list of the clinical trial sites, please click here.
Question 5: Will more U.S. clinical trial sites become available for treatment with DCVax®-L?
Answer 5: We plan to add additional U.S. medical centers over the coming months, and will be posting those centers as the arrangements are finalized. Please continue to visit our website for periodic updates.
Question 6: Is treatment currently available in Switzerland? Who can I contact in Switzerland to inquire about treatment?
Answer 6: We are in the process of completing certain standard implementation steps (i.e., contract arrangements with the medical centers). Contact information will be available as soon as all arrangements have been finalized. Please continue to visit our web site to check for periodic updates.
Question 7: I am not eligible for the current U.S. clinical trials, what else can I do?
Answer 7: You may want to consider other clinical trials for your type of cancer, there are various trials that are open for enrollment. You can find these trials through a search at www.clinicaltrials.gov and follow-up with your treating physician.
Question 8: Have children been treated with DCVax®-L?
Answer 8: To date, DCVax®-L has been tested only in adults, and has not yet been tested in children below age 18.
Question 9: Can I get updates as more information becomes available?
Answer 9: Please click here to subscribe to our mailing list and we will send you updates as they become available.
Question 10: I still have more questions; can you point me to more resources?
Answer 10: Please check the Related Links section for more resources.
Please note that Northwest Biotherapeutics makes no representations about the accuracy or completeness of the information provided in the websites listed.
|
